Why the study?
Does antihypertensive therapy, specifically ACE inhibitors and calcium channel blockers, improve outcomes and quality of life in elderly patients with hypertension?
Does antihypertensive therapy, specifically ACE inhibitors and calcium channel blockers, improve outcomes and quality of life in elderly patients with hypertension?
Answers are grounded in this paper and cite their sources.
ACE inhibitors and calcium channel blockers are recommended as first-line antihypertensive therapy in elderly patients due to their efficacy in reducing cardiovascular events and favorable side effect profiles.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bursztyn et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: